Biosimilars backed by Patent Expiry to Drive the Ankylosing Spondylitis Treatment Market
As per a report available on XploreMR, the global ankylosing spondylitis treatment market will enter the growth zone between 2020 and 2030.
The ankylosing spondylitis treatment market is driven by biosimilars making an entry therein. Also, ankylosing spondylitis’ prevalence is increasing at a substantial rate. This is evident from the study published by Oxford University Press. It states that Europe has cases between 1.3 Mn and 1.56 Mn and the Asia-Pacific between 4.63 Mn and 4.98 Mn.
The factors mentioned above are likely to take the ankylosing spondylitis treatment market by storm in these two geographies.
What more could be taken from Ankylosing spondylitis treatment market?
The key players are collaborating to bring out novel products. For instance – Eli Lilly and Company, in Aug 2019, did receive approval for the product “Taltz Injection 80 mg/ml” from the US FDA to treat ankylosing spondylitis. Also, in Nov 2019, “Abrilada”, biosimilar from Humira was approved by the US FDA to treat ankylosing spondylitis.
In Oct 2019, the European Commission approved Cosentyx from Novartis to treat non-radiographic axial spondyloarthritis. Novartis is also planning to submit label update application to the same US FDA. The period post-approval is expected to bring in more revenue in the forecast period.
At the same time, it needs to be noted that patent expiry on the part of blockbuster drugs hampers the growth of the market.
The global ankylosing spondylitis treatment market constitutes North America (Canada, US), Eastern Europe (Russia and Poland), Western Europe (Luxembourg, The Netherlands, Belgium, Nordic countries, Italy, Spain, France, UK, Germany), Asia-Pacific (New Zealand, Australia, ASEAN, Japan, India, China), MEA (North Africa, Southern Africa, GCC), and Latin America (Chile, Peru, Brazil, Mexico, and others).
North America alone accounts for more than 60% of market share due to higher prevalence of ankylosing spondylitis in Canada and the US. Also, branded drugs’ expiry has paved the way for entry of biosimilars. For example – Remicade’s patent expiry in the year 2015 did result in “Inflectra” to surface in 2016, Renflexis & Ixifi in the year 2017, and “Avsola” in the year 2019. Also, inorganic expansion is on the anvil. For instance – TrialSpark entered into collaboration with Novartis AG in Jan 2019 with an objective of increasing patients’ access to the clinical trials. The collaboration is likely of shortening enrollment timeline, thereby helping in quicker development on the part of novel therapies. New York has also witnessed trials in several sites for looking through treatment for ankylosing spondylitis.
Europe stands second on the similar grounds. The Asia-Pacific is expected to grow at the fastest pace in the forecast period. This could be credited to increase in incidences of diseases across Indonesia, India, and China.
The key market participants include Pfizer, Inc., UCB, Inc., Amgen, Inc., AbbVie, Inc., Eli Lilly and Company, Johnson & Johnson Services, Inc., and Merck & Co., Inc. label extension is being practiced by some of them to have a greater market share. For example – AbbVie Inc., in May 2019, did announce Humira’s patent extension till the year 2023 in the US. This followed settlement on the part of “Boehringer Ingelheim International GmBH”.
A recent market study published by XploreMR on the Ankylosing Spondylitis Treatment Market offers global industry analysis for 2015-2019 & opportunity assessment for 2020-2030. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the market, growth prospects of the market are obtained with utmost precision.
Ankylosing Spondylitis Treatment Market: Global Industry Analysis 2015-2019 & Opportunity Assessment 2020-2030
The report features unique and salient factors that may make a huge impact on the development of the Ankylosing Spondylitis Treatment Market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the market in the years to come. The report provides detailed information about the current and future growth prospects of the market in the most comprehensive way for better understanding of readers.
Key Segments of Ankylosing Spondylitis Treatment Market
XploreMR’s study on the market offers information divided into four important segments— Drug Class, Route of Administration, Application, and Region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Route of Administration
Chapter 1 – Executive Summary
The report commences with the executive summary of the Ankylosing Spondylitis Treatment Market report, which includes the snapshot of key findings and statistics. It also includes the market value (US$ million) estimates of the leading segments of the market and the key trends impacting the market.
Chapter 2 – Market Overview
Readers can find detailed taxonomy and product definition of the Ankylosing Spondylitis Treatment Market in this chapter, which will help them understand basics of ankylosing spondylitis.
Chapter 3 – Key Market Trends
This section highlights the key trends impacting the market, which will help readers understand the current trends and their impact on market growth.
Chapter 4 – Key Success Factors
This chapter explains the key macroeconomic factors that are expected to influence the growth of the market during the forecast period. It also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the market, which include the drivers, restraints, and opportunities.
This chapter is expected to enable readers understand the factors that are propelling the growth of the market, as well as those likely to hamper the growth. The opportunity analysis for the ankylosing spondylitis treatment will help readers understand the market opportunities, based on which they can plan their strategies.
In addition, this section provides the current and expected impact of Covid-19 on the market.
Chapter 5 – Global Ankylosing Spondylitis Treatment Market – Pricing Analysis
This chapter explains the pipeline assessment, key regulations for product launch in various countries along with disease epidemiology that are expected to influence the growth of the market during the forecast period.
Chapter 6 – Global Ankylosing Spondylitis Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
This section explains the global market value analysis and forecast for the market during the forecast period along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).
Chapter 7 – Market Background
This chapter gives information about COVID-19 crisis impact analysis that comprises current COVID-19 statistics and probable future impact, impact on GDP of individual key countries, segment wise impact, quarter-wise forecast, and projected recovery quarter. In addition, it includes drivers and restraints of the market. Plus, there are macroeconomic factors and various opportunities listed for the ankylosing spondylitis treatment market.
Chapter 8 – Global Ankylosing Spondylitis Treatment Market Analysis (2015-2019) and Forecast (2020-2030), By Drug Class
Based on drug class, the market is segmented into Nonsteroidal Anti-inflammatory Drugs, Anti-Inflammatory Drugs, Immunosuppressive Drugs, TNF Blockers, JAK Inhibitors, Steroids, Biologics, and Others. In this chapter, readers can find a detailed analysis of the market by different classes of drugs regarding ankylosing spondylitis treatments and their growth over the forecast period.
Chapter 9 – Global Ankylosing Spondylitis Treatment Market Analysis 2015-2019 and Forecast, 2020-2030, By Route of Administration
Based on route of administration, the market spans parenteral and oral. In this chapter, readers can find information on market attractiveness based on route of administration.
Chapter 10 – Global Ankylosing Spondylitis Treatment Market Analysis 2015-2019 and Forecast, 2020-2030, By Application
Based on source, the market comprises adults and juveniles. In this chapter, readers can find information on market attractiveness based on application.
Chapter 11 – Global Ankylosing Spondylitis Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Region
This chapter explains how the market will grow across various regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).
Chapter 12 – North America Ankylosing Spondylitis Treatment Market Analysis 2015-2019 and Forecast 2020-2030
This chapter includes a detailed analysis of North America’s Ankylosing Spondylitis Treatment Market along with the country-wise assessment including the U.S. and Canada.
Chapter 13 – Latin America Ankylosing Spondylitis Treatment Market Analysis 2015-2019 and Forecast 2020-2030
This chapter includes the growth prospects of the Ankylosing Spondylitis Treatment Market in Brazil, Mexico, and the rest of Latin America. Readers can find thorough information about the growth parameters of the Latin America’s Ankylosing Spondylitis Treatment Market during 2020-2030.
Chapter 14 –Europe Ankylosing Spondylitis Treatment Market Analysis 2015-2019 and Forecast 2020-2030
Important growth prospects of the Ankylosing Spondylitis Treatment Market based on product type, form, source, application in the U.K., Germany, France, Italy, Spain, Russia, BENELUX, and Rest of Europe are included in this chapter.
Chapter 15 – South Asia Ankylosing Spondylitis Treatment Market Analysis 2015-2019 and Forecast 2020-2030
India, Indonesia, Malaysia, Thailand, and the rest of South Asia are the leading countries/regions in South Asia that are the prime subjects of assessment to obtain the growth prospects of the South Asia’s Ankylosing Spondylitis Treatment Market. In this chapter, readers can find thorough information about the growth parameters of the South Asia’s Ankylosing Spondylitis Treatment Market during 2030.
Chapter 16 – East Asia Ankylosing Spondylitis Treatment Market Analysis 2015-2019 and Forecast 2020-2030
Detailed information about factors such as incremental opportunity, Y-O-Y growth, and regional trends that are impacting the growth of the East Asia’s Ankylosing Spondylitis Treatment Market are included in this chapter. It also includes the growth prospects of the market in leading East Asian countries such as China, Japan, and South Korea.
Chapter 17 – Oceania Ankylosing Spondylitis Treatment Market Analysis 2014–2018 and Forecast 2020–2030
This chapter consists of important parameters that have a huge impact on the growth of the market in Oceania, based on market segmentation, during the forecast period. It also provides an overview of the drivers, restraints, and trends in the Oceania’s Ankylosing Spondylitis Treatment Market.
Chapter 18 – MEA Ankylosing Spondylitis Treatment Market Analysis 2015-2019 and Forecast 2020-2030
This chapter provides information on how the market will grow in the major countries in GCC Countries, South Africa, Northern Africa, Turkey, and Rest of MEA during 2020-2030.
Chapter 19 – Key and Emerging Countries Ankylosing Spondylitis Treatment Market Analysis 2015-2019 and Forecast 2020-2030
This chapter provides information about the way the market will grow in the in the emerging economies as well as the key players in the forecast period (2020-2030).
Chapter 20 – Market Structure Analysis
This chapter highlights the tier structure analysis, market concentration analysis, and company share analysis along with sales footprint analysis of key player operating in ankylosing spondylitis treatment market.
Chapter 21 – Competitive Analysis
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Ankylosing Spondylitis Treatment Market, along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Players featured in the market report include Wyeth, Mitsubishi Tanabe, Schering-Plough, Takeda, Amgen, Centocor, Abbott, Eisai, and Pfizer.
Chapter 22 – Assumptions and Acronyms Used
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.
Chapter 23 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information.
Ankylosing Spondylitis Treatment Market Forecast, Trend Analysis & Opportunity Assessment 2020-2030Buy Now
Custom Market Research Services
xploreMR offers custom market reserch services that help clients to get information on their business scenario required where syndicated solutions are not enough
Why Choose XploreMR
Our analysts go above and beyond to answer your specific queries. We are with you throughout the entire journey – from initial discussion to post-purchase.
Country-wise Analysis & Forecasting
As we track markets at country-level, we are able to offer hard-to-find market intelligence in both developed and emerging countries.
High Quality At Competitive Pricing
We believe high quality market research shouldn’t be out of reach for businesses. Our competitively-priced market research reports ensure businesses of all sizes have access to quality information
A recent market study published by XploreMR on the cell culture media bags market including global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, delivers a comprehensive ...
Sinus Therapeutic Drugs Market Analysis 2020-2030 A recent market study published by XploreMR on the Sinus Therapeutic Drugs Market including global industry analysis for 2015-2019 & opportunity ...